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INTRODUCTION 
“It is the duty of the anaesthesiologist to study the well being of 
the patient as well as the convenience of the surgeon” 
                                                                          -R.M.WATERS 
“The proper dose of any drug is enough” 
                                                             – THOMAS SYDENHAM 
The anaesthesiologist chooses a drug or mixture of drugs that 
best fits the anticipated needs of the operation and as laycock in 1953 
has written “Reflexes are his essential guides in this matter. He must 
understand them, look out for them, nurse them, leave them alone, 
depress or abolish them”  
                                                                 - WYLIE 
“It is not the drug that is dangerous, but the man who 
administers it is”   
                                                      -  SIR ROBERT MACINTOSH 
Cerebrospinal fluid discovered by Domenico cotungo in 1764 and 
its circulation described by F.Magendie in 1825.  First spinal analgesia by 
J.Leonard corning in 1885. He accidentally pierced the dura  while 
experimenting with cocaine on the spinal nerves of the dog. Later he  
deliberately repeated the intradural injection,  called it  spinal anaesthesia 
and suggested it might be used in surgery. 
           First planned spinal analgesia for surgery in man performed by 
August Bier on 16th  august 1898, in kiel when he injected 3 ml of 0.5 % 
cocaine solution into a 34 year old labourer.  
For inguinal hernia surgeries, the standard  anaesthetic technique is 
subarachnoid block. Adrenaline being the first spinal adjuvant used to 
increase the duration and to reduce the toxicity of spinal anaesthesia in 
1903. From then many drugs have been tried in search for an ideal 
adjuvant.  They are opioids, soda bicarbonate, ketamine, neostigmine, 
midazolam and the latest inclusion is clonidine. 
ADVANTAGES: 
 Initially  opioids  have been the standard choice as spinal adjuvants. 
But since there occurs many side effects and complications like early and  
late depression of ventilation , pruritus, nausea, vomiting,   urinary 
retention,     central nervous system excitation, viral re activation, sexual 
dysfunction, delayed gastric emptying, ocular dysfunction,  there is an 
active search for an alternative  ideal  adjuvant which is devoid of these 
side effects and complications. 
Preservative free clonidine when administered into epidural or 
subarachnoid space  produce dose dependent analgesia and unlike opioids 
does not produce any of its side effects.  Activation   of    post synaptic 
alpha 2  receptors in the substantia gelatinosa of the spinal cord is the 
presumed mechanism by which it produces analgesia. 
    Clonidine at appropriate doses  when used as  an adjuvant with 
bupivacaine in subarachnoid block seems to prolong the duration of 
surgical anaesthesia  and postoperative  analgesia  without any of its  side 
effects like dry mouth, hypotension, bradycardia, which is not usual in 
these doses with added advantages like sedation, anti- shivering. 
           This study has been taken in search for a minimal dose of clonidine 
as an adjuvant with bupivacaine which produces maximum post operative 
analgesia without or with minimal incidence of its side effects. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
AIM OF THE STUDY 
 
    The aim of this study is to evaluate  the duration of post 
operative analgesia provided by two varying doses of clonidine with 
bupivacaine against bupivacaine alone in subarachnoid blockade in  
inguinal hernia surgeries.  
 
 
 
 
 
 
 
 
 
ANATOMY OF SUBARACHNOID SPACE 
 
 Subarachnoid block means the temporary interruption of nerve 
transmission within the subarachnoid space produced by injection of a 
local anaesthetic solution into cerebrospinal fluid. 
Applied anatomy of vertebral canal: 
 Vertebral canal extends from foramen magnum to the sacral hiatus. 
It protects the spinal cord. 
 The vertebral column comprised 33 vertebrae (7-cervical, 12-
thoracic, 5-lumbar, 5-fused sacral and 4-coccygeal) and four curves. 
Cervical and lumbar curves are convex anteriorly and thoracic & sacral 
curves are convex posteriorly. The curves of the vertebral column 
influences the spread of the local anaesthetic in the subarachnoid space. 
 Each vertebra is composed of a body separated from the adjacent 
vertebra  by intervertebral disc  and formed by pedicles and laminae, which 
surround and protect the cord laterally and posteriosly. 
 The vertebral column is bound together by several ligaments. They 
are, 
1. Supraspinous ligament – passes longitudinally over the tips of the 
spinous processes from C7 to the sacrum. 
2. Interspinous ligament – connects the adjoining spinous processes 
together.  
3. Ligamentum Flavum – known as yellow ligament, connects the 
adjacent laminae composed of yellow elastic fibres. They become 
progressively thicker from above downwards. 
4. Posterior longitudinal ligament – It is on the posterior surface of 
bodies of vertebra. 
5. Anterior longitudinal ligament – It runs along the front of the 
vertebral bodies. 
There are seven projections from these vertebral (or) neural arches. 
They are, 
a) Three muscular processes – (2-Transverse processes, 1-spinous 
process for the attachment of muscle and ligaments). 
b) Four articular process – Two upper & two lower which in the 
lumbar region prevent rotation but allow limited flexion and 
extension between contiguous vertebrae. 
Vertebral canal formed by these structures has deficiencies 
posteriorly in the midline called inter laminar foramina which enlarge in 
flexion accessible for the passage of spinal needle. The direction of 
spinous process determine the direction of spinal needle. 
 
SPINAL CORD: 
 It is the direct continuation of the medulla oblongata extending from 
the upper border of the atlas to the first lumber vertebra below which there 
is leash of nerve roots termed cauda equina. Spinal nerves are 31 pairs 
totally. 
 8  –  Cervical 
 12  –  Thoracic 
 5  –  Lumbar 
 5  –  Sacral 
 1  –  Coccygeal          
 Each of the spinal nerve is composed of anterior and posterior roots 
uniting at the intervertebral foramina and form a nerve trunk. Membranes 
covering the spinal cord from without are dura mater, arachnoid mater and 
piamater. Dura and arachnoidmater ends at S2 level. Piamater is closely 
applied to the spinal cord. 
 
BLOOD SUPPLY: 
 It is from the anterior spinal artery which is a branch of vertebral 
artery and also by a pair of posterior spinal arteries which arise from the 
posterior inferior cerebellar arteries. There is no anastamosis between these 
arteries. 
SPINAL VEINS: 
 The spinal veins are arranged into anterior and posterior plexus 
which are draining into vertebral, azygos and lumbar veins.        
CEREBROSPINAL FLUID: 
 This is an ultrafiltrate of the blood plasma from choroids plexus of 
the lateral ventricles with a pH of 7.32 (7.27-7.37) 
 
 It is a clear, colourless fluid found in the cranial and spinal 
subarachnoid space and in the ventricle of the brain.  The total volume of 
CSF in an average adult ranges from 120-150ml of which 25-35ml is in the 
spinal subarachnoid space. 
Composition of cerebrospinal fluid: 
Specific gravity  - 1.006 (1.003-1.009) at 370C   
Pressure   - 60-80mm of water 
Pco2    - 48mmHg 
Bicarbonate   - 23meq/l 
Sodium   - 133-145meq/l 
Calcium   - 2-3meq/l 
Phosphate   - 1.6mg/dl 
Magnesium   - 2-2.5mg/l 
Chloride   - 15-20meq/l 
Protein   - 23-38mg/dl 
Sugar    - 45-80mg/dl 
Lymphocytes  - 0-5cells/cmm 
 An important factor that determine the spread of drug in 
cerebrospinal fluid is the baricity of the solution. Baricity is the density of 
the solution in relation to cerebrospinal fluid. The density of the solution is 
the mass of drug (gram) per ml of the solution. 
PHYSIOLOGY OF SUBARACHNOID BLOCK 
 Subarachnoid block implies the temporary interruption of nerve 
transmission within the subarachnoid space by injection of local 
anaesthetics. The blockade of nerve fibres occur in the order of 
Temperature, Pain, proprioceptive and then motor fibres.   
FACTORS INFLUENCING BLOCK HEIGHT: 
a - Site of injection  
b - Angulation of needle  
c - Characteristic of local anaesthetic- baricity 
d - Dose of local anaesthetic 
e - Position of the patient during and after injection 
f - Anatomic configuration of spinal column. 
g - Patient height (at extremes) 
h - Volume of cerebrospinal fluid 
i - Reduced cerebrospinal fluid with increased intra abdominal  
 pressure (eg. Pregnancy) 
 
 
a) Effects on Cardio Vascular System:    
 Most important physiological responses to subarachnoid block 
involve cardiovascular system due to combined effect of autonomic 
denervation, higher level of neural block, added effect of vagal 
innervation.  
 Local anaesthetics and vasoactive substances administered in small 
doses intrathercally leads to direct cardiovascular effect. 
 Level of sympathetic denervation determines the magnitude of 
cardiovascular system responses, but the relationship is neither predictable 
nor precise. 
 Sympathetic denervation produces arterial and more physiologically 
important arteriolar dilatation and vasodilatation in the venous circulation 
produces fall in blood pressure. 
 Due to Bainbridge reflex, the fall in blood pressure is associated 
with bradycardia, blockade of cardiac sympathetic fibres from T1-T4 is an 
additional factor that causes bradycardia.  
b) Effects on Respiratory System: 
 Respiration is not depressed normally. High spinal can cause 
paralysis of intercostal muscles but the resting tidal volume, maximum 
inspiratory volume, respiratory rate, negative intrapleural pressure and also 
the phrenic nerve are unaffected. Hypoxia may accompany hypotension 
and is corrected by oxygen administration via face mask. 
c) Gastro Intestinal Effect: 
 Preganglionic fibres from T5-L1 are inhibitory to gut. So in 
sympathetic blockade the small intestine contracts with relaxed sphincters 
and peristalsis remains normal. Handling of viscera causes discomfort and 
bradycardia since vagus is not blocked. 
d) Hepatic and Renal Effects: 
 The hepatic blood flow decreases and is directly proportional to the 
decrease in blood pressure. There may be normal hepatic oxygen 
extraction. Renal blood flow is maintained by autoregulation and does not 
decrease till mean arterial pressure goes below 50mmHg. 
e) Genito Urinary System:           
 Sphincters of bladder are not relaxed, and the ureteric tone are not 
greatly altered. Urinary retention occurs. Penis is often engorged. Uterine 
tone is unchanged in pregnancy. In the absence of hypotension spinal 
anaesthesia has got no effect on the progress of labour and uterine blood 
flow.  
f) Metabolic and hormonal effect: 
 Spinal anaesthesia blocks the hormonal and metabolic responses to 
nociceptive stimuli arising from the operative site. It minimizes the rise in 
blood sugar, coritsol, catecholamines renin and aldosterone release 
associated with stress. Post operative negative nitrogen balance and 
secretion of antidiuretic hormone are inhibited.  
g) Thermo Regulation: 
 Hypothermia results from heat loss to the cold environment due to 
vasodilatation. 
INGUINAL HERNIA SURGERIES: 
    Among the infraumbilical surgeries inguinal hernia surgeries  stands 
one of  the commonest indications  in adults. Its a protrusion of abdominal 
content, omentum through the superficial inguinal ring. The usual mode of 
anaesthetic plan is subarachnoid block. And if it is strangulated , combined 
epidural spinal blockade or general anaesthesia sometimes are the 
techniques since resection anastamosis may be done . 
It may be a bubonocoele, incomplete or complete hernia. According 
to its site of exit it may be indirect or direct hernia. According to contents 
it may be enterocele, epiplocele, cystocele.  Also it may be reducible, 
irreducible, obstructed (incarcerated), strangulated and inflammed hernia. 
 
 
 
 
                 
 PHARMACOLOGY OF DRUGS 
a) Bupivacaine: 
 Bupivacaine is an amide linked local anaesthetic. It is a 
hydrochloride salt of 1-butyl-N-(2, 6-dimethylphenyl) piperidine-2- 
carboxamide and is presented as a racemic mixture. 
¾ It was synthesized by Ekenstem in 1957. 
¾ First reports of its use was published in 1963 by Telivuo. 
¾ It is derived from Mepivacaine and is very stable compound and 
may be autoclaved repeatedly. 
Pka is 8.1 
Molecular weight   -  288  
Protein binding    - 95% 
Lipid solubility   -  28 
Elimination half life  -  210mts 
Toxic plasma concentration -  >1.5μg/ml 
Approximate duration of action -  175mts 
Availability: 
 Ampoules -  0.5% Bupivacaine hydrochloride 4cc 
-      0.5% Bupivacaine hydrochloride with dextrose  
(heavy) 4cc 
 Vials  -      0.25% and 0.5% Bupivacaine hydrochloride 20cc 
 Dosage -   Maximum dosage 3mg/kg body weight. 
Uses: 
¾ Spinal anaesthesia 
¾ Epidural anaesthesia 
¾ Caudal anaesthesia 
¾ Continuous epidural anaesthesia 
¾ Peripheral nerve block 
 
Onset time and duration of action 
Site of action Onset (minutes) Duration (minutes) 
Intrathecal  5 90-120 
Epidural 15-20 165-225 
Brachial plexus 10-20 600 
 
Pharmacokinetics: 
 Once injected intrathecally, it gets absorbed by the nerve rootlets 
and results in the desired effect. It is rapidly absorbed from the site of 
injection, but the rate of absorption depends on the vascularity at the site 
and the presence of vasoconstrictors. 
 High lipid solubility of bupivacaine makes it easy for nerve and 
vascular tissue penetration. 
 80-95% of the absorbed bupivacaive binds to the plasma proteins. 
Distribution: 
 Rapid distribution phase: (α) 
In this phase the drug is distributed to highly vascular region t1/2 of 
α  - being 2.7 minutes.      
 Slow disappearance phase: (β) 
In this phase the drug distributes to slowly equilibrating tissues t1/2 
of β – being 28mts.  
 Biotransformation and excretion phase δ  
 T1/2 of δ is 3.5hours clearance is 0.47 litre/minute. 
Biotransformation: 
 Possible pathways of metabolism of bupivacaine include aromatic 
hydroxylation and conjugation. Only the N-dealkylated metabolite, N-
desbutyl bupivacaine has been measured in blood (or) urine after epidural 
(or) spinal anaesthesia. Alpha1 acid glycoprotein is the most important 
plasma protein binding site of bupivacaine and its concentration is 
increased by many clinical situations including post operative trauma. 
Excretion: 
 It is through the kidney, 4-10% of the drug is excreted unchanged. 
Mode of Action: 
a) Site of action: 
i) The spinal nerve rootlet fine nerve filaments having a large surface 
area are exposed to the local anaesthetics.  
ii) Posterior and lateral aspects of the spinal cord itself. 
 
 
b) Sodium Channel blockade: 
 They impede sodium ion access to the axon interior  by occluding 
the transmembrane sodium channels thus delaying the process of 
depolarization and axon remains polarized. It is a non-depolarisation 
blockade.     
Pharmacodynamics: 
 It has got a longer duration of action but a slower onset. 
Cardiovascular system: 
 It reduces cardiac output by reducing the sympathetic tone, by 
slowing the heart rate and by reducing the venous return, it produces a fall 
in arterial blood pressure but it is relatively slow and is seldom very 
profound. 
 It produces a fall in central venous pressure. It causes an increase in 
lower limb blood flow. It causes a reduction in incidence of deep vein 
thrombosis. 
Respiratory System: 
          It relaxes bronchial smooth muscle. Apnea can results 
from phrenic and intercostal nerve paralysis or depression of the 
medullary respiratory center following direct exposure to drug. 
 
 
Gastro intestinal tract: 
 There is an increase in gastro intestinal motility and emptying of the 
gastric contents are better.   
 Toxicity: 
 Toxicity is related to plasma level of unbound drug and more likely 
due to an inadverdant intravenous injection. Systemic toxicity reactions 
primarily involve central nervous system and cardio vascular system. The 
blood level required to produce central nervous system toxicity is less than 
that required to produce circulatory collapse.  
Central Nervous System Toxicity:  
        Early symptoms are circumoral numbness, tongue paresthesia, 
and dizziness. Sensory complaints include tinnitus and blurred vision. 
Excitatory signs ( restlessness, agitation, nervousness,paranoia) often 
precede central nervous system depression (slurred speech, 
drowsiness, unconsciousness). Muscle twitching heralds the onset of 
tonic clonic seizures. Respiratory arrest often follows. The excitatory 
reactions are the  result of selective blockade of inhibitory pathways. 
 Cardiovascular System Toxicity: 
 The rate of depolarization in fast conducting tissue of purkinje 
fibres and ventricular muscle is decreased. The rate of recovery of 
bupivacaine induced block is slower than that of lignocaine. 
Extremely high concentration of the drug causes sinus bradycardia, 
hypotension, atrioventricular heart block, idioventricular rhythms, and 
life threatening arrhythmias such as ventricular tachycardia, 
ventricular fibrillation and cardiac arrest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PHARMACOLOGY OF CLONIDINE HYDROCHLORIDE 
Introduction:  
             Clonidine hydrochloride is a centrally acting selective partial 
alpha -2 agonist introduced in early 1960s, it was during its use as a 
nasal decongestant that its anti- hypertensive property was found out. 
Subsequently more insights into the pharmacological properties has 
led to its use in clinical anaesthesia practice as well.  
          Clonidine hydrochloride is an imidazoline compound and  
exists as a mesomeric compound. The chemical name is 2-(2,6- 
dichlorophenylamino)-2-imidazoline hydrochloride. The structural  
formula is C9H9C12N3HCl. 
   The molecular weight is 266.56. Clonidine is an  odourless, 
bitter, white, crystalline substance, soluble in alcohol and water. 
Clonidine improves the quality of anaesthesia, provides a more stable 
cardiovascular course during anaesthesia, presumably because of their 
sympatholytic effect and need for lower dose of cardioactive 
anaesthetic and reduces the dose requirement of the anaesthetic agent. 
Clonidine may reduce the halothane MAC by upto 50% in a dose 
dependent manner.  Clonidine potentiates the anaesthetic action of the 
local anaesthetics with fewer side effects in peripheral nerve blocks 
and central neuraxial blockade. 
Availability:          
        Available as one ml ampoule containing 150 micrograms.It 
should be stored below 25oc.  
Mechanism of action: 
        Clonidine is a centrally acting selective partial α2 adrenergic 
agonist with a selectivity ratio of 220: 1 in favour of α2 receptors.  
The three subtypes of α2 receptors are α2a, α2b, α2c. α2a receptors 
mediate  sedation, analgesia,  sympatholysis . α2b receptors mediate 
vasoconstriction and anti- shivering. The startle response may reflect 
the activation of α2c receptors.   The drug is lipid soluble, penetrates 
the blood brain barrier to reach the hypothalamus and medulla when 
injected epidurally.  It stimulates the inhibitory α2 adrenoreceptors to 
reduce the central neural transmission in the spinal neurons.  
Inhibition of substance- P release is believed to be involved in the 
analgesic effect.  
  The α2 adrenoreceptors are located on the afferent terminals of 
both peripheral and spinal neurons in the superficial laminae of the 
spinal cord and within several brain stem nuclei implicated in 
analgesia.  The superficial laminae contain three groups of neurons: 
tonic, adapting, single- spike firing, all of which receive their primary 
sensory input from Aδ and C fibres. Clonidine inhibits voltage gated 
Na+ and K+ channels and suppresses the generation of action 
potentials in tonic- firing spinal dorsal horn neurons, contributing to 
analgesic effect. The ability of clonidine to modify the function of 
potassium channels in the CNS (cell membrane become 
hyperpolarized) may be mechanism for profound decrease in 
anaesthetic requirements.  
            Another contribution to analgesic effect may be through the 
 release of acetylcholine in the neuraxial region. The α2 adrenergic  
agonists also enhance analgesia from intraspinal opioids. Sedation is  
produced by its action on locus ceruleus.  
         Clonidine affects the blood pressure in a complex fashion after 
neuraxial or systemic administration because of opposing action at 
multiple sites.  In the nucleus tractus solitarius and locus ceruleus of  
the brain stem, activation of post- synaptic α2 adrenoreceptors 
reduces sympathetic drive. It also activates nor-adrenergic 
imidazoline preferring binding sites in the lateral reticular nucleus 
producing hypotension and anti- arrythmogenic action. In the 
periphery it acts on pre-synaptic α2 adrenoreceptors at sympathetic 
terminals reduces the release of nor-epinephrine causing 
vasorelaxation and reduced chronotropic drive. The brainstem and the 
peripheral effects of α2 adrenoreceptor stimulation are 
counterbalanced by the direct peripheral vasoconstriction through its 
action on α2 adrenoreceptors from the circulating concentrations of 
clonidine. 
           Sedation is a desired property. Clonidine produces a dose 
dependent sedation at the dose of 50 mics or more in less than 20  
minutes regardless of the route of administration. 
Clonidine doesn’t induce profound respiratory depression even 
after massive overdose nor do they potentiate respiratory depression 
from opioids. 
In peripheral nerves it produces a minor degree of blockade at 
high concentrations with some preference for C- fibres in the 
peripheral nerves and this effect in part enhance the peripheral nerve 
block when added to local anaesthetics, probably because the 
α2adrenoreceptors are lacking on the axons of peripheral nerves. 
Pharmacokinetics; 
           Clonidine is well absorbed orally and is nearly 100% bio 
available and reaches peak plasma concentration within 60 to 90 
minutes. The mean half life of the drug in plasma is about 9 to 12 
hours, with approximately 50% metabolized in the liver whereas is it 
is excreted in an unchanged form by the kidney, and its half- life can 
dramatically increase in the presence of impaired renal function.  
 A transdermal delivery system is available in which the drug is  
released at a constant rate for about a week. Three or four days are  
required to achieve steady state concentration. 
        Clonidine is highly lipid soluble and readily distributes into 
extra- vascular sites including the central nervous system. 
 300 micrograms intravenously over 10 min produces: 
    Distribution t ½    :    11 ± 9 minutes. 
    Elimination t½   :   9 ± 2 hour, 41 hours in severe  
          Renal dysfunction. 
    Volume of distribution : 2.1 ± 0.4 l/kg 
    Plasma protein binding  : 20-40 % in vitro. 
    Metabolism   :  minor pathways with the major  
        Metabolite, p- hydroxyclonidine. 
  Excretion:  
70% of the dose, mainly in the form of unchanged parent drug 
(40-60%) in urine. 
           So, the elimination t1/2 of clonidine varies as a function of 
 creatinine clearance.  In subjects undergoing hemodialysis only 5% 
of the body clonidine store was removed. 
Dosage regimen;  
        Oral                    -   3-5 μg/kg 
        Intramuscular     -   2 μg/kg 
        Intravenous        -   1-3 μg/kg 
       Epidural               -  1-2 μg/kg 
      Transdermal          -  0.1- 0.3 mg released per day  
Precautions: 
1. In patients with renal insufficiency, lower dose is needed.  
2.  Sudden withdrawal of prolonged continuous epidural infusion 
 produces hypertensive crisis. So it should be gradually 
discontinued over 2 to 4 days. 
3. Use with caution in patients with cerebrovascular or coronary 
insufficiency. 
4. If a patient with beta blocker is on continuous epidural therapy, 
beta blocker should be withdrawn several days before 
discontinuation of epidural clonidine. 
5. Intrathecal / epidural clonidine often causes bradycardia that if 
symptomatic can be treated with inj. Atropine. 
Contraindications: 
1. Known hypersensitivity to clonidine or components of the 
 product. 
2. In patients with brady arrhythmia or AV block. 
3. Patients with severe cardiovascular disease 
4. Patients with cardiovascular / hemodynamic instability. 
Interactions:    
1. Clonidine may potentiate the CNS- depressive effect of alcohol, 
barbiturates or other sedative drugs. 
2. Narcotics may potentiate the hypotensive effects of clonidine. 
3. Tricyclic anti depressants may antagonize the hypotensive 
effects of clonidine. 
4.  Concomitant administration of drugs with a negative 
chronotropic/ dromotropic effect (beta blockers, digoxin) can 
cause or potentiate bradycardiac rhythm disturbances. 
5. Beta blockers may potentiate the hypertensive response seen 
with clonidine withdrawal. 
6.    Epidural clonidine may prolong the duration of pharmacologic 
effects of epidural local anaesthetics, opioids, neostigmine and other 
drugs.  
USES: 
1.    Preanaesthetic Medication; 
Oral clonidine  Preanaesthetic medication (5 μg/kg ) (a) 
blunts reflex tachycardia associated with direct laryngoscopy 
for intubation of trachea, (b) decrease intraoperative lability of 
blood pressure and heart rate, (c) decrease plasma 
catecholamine concentrations, and (d) dramatically decrease 
anaesthetic requirements for inhaled  and injected drugs.  
Clonidine also attenuates the rise in intraocular pressure 
associates with laryngoscopy and intubation.  
2. Epidural block:  Clonidine as a sole agent or in combination 
with opioids or local anaesthetics to provide excellent analgesia 
in labour analgesia. Epidural clonidine is also indicated for the 
treatment intractable pain, which is unresponsive to maximum 
dose of oral or epidural opioid, as do patients with reflex 
sympathetic dystrophy, neuropathic pain.  
3. Spinal anaesthesia: Clonidine combined with local anaesthetics 
improves the quality and duration of the block, minimize the 
tourniquet pain during lower limb surgery, and prevents 
shivering. 
4. Caudal anaesthesia: clonidine combined with local anaesthetics 
increases the duration of anaesthesia and analgesia by 2 or 3 
times without hemodynamic side effects. Dose 2-3 μg/kg 
5. Peripheral nerve blocks: Clonidine prolongs the duration of 
anaesthesia and analgesia with local anaesthetics by two times 
in a dose of 75 to150 micro grams. 
6. Bier’s block: 150 microgram of clonidine enhances the    
tolerance of tourniquet                                            
7.  It is also used in intra articular analgesia. 
8.     Protection against perioperative myocardial ischemia; clonidine       
decreases myocardial ischemia, infarction and mortality 
following cardiovascular surgery.  
9.      Clonidine is used in the treatment of hypertensive crises 
10.  Diagnosis of pheochromocytoma; clonidine, 0.3 mg will 
decrease the plasma concentrations of catecholamine in normal 
patients but not in the presence of pheochromocytoma. 
11.  Treatment of shivering; Administration of clonidine, 75 μg IV 
stops   shivering by inhibiting thermoregulatory control. 
12.   Treatment of opioid and alcohol withdrawal syndrome 
  
Side effects : 
1. The most common side effects are sedation and xerostomia.  
2. Cardiovascular complaints are bradycardia, hypotension, and ECG 
abnormalities like sinusnode arrest, junctional bradycardia; high 
degree AV block and arrhythmia are reported rarely. Occasionally 
require treatment of bradycardia with I.V anticholinergics.   
Orthostatic hypotension occurs rarely. 
3. Rebound hypertension; Abrupt discontinuation of clonidine can 
result in rebound hypertension as soon as 8 hours and as late as 36 
hours after the last dose. Symptoms of nervousness, diaphoresis, 
headache, abdominal pain, and tachycardia often precede the actual 
increase in systemic blood pressure. Labetalol is useful in treatment 
of rebound hypertension. 
4.  Skin rashes are occurs frequently. 
5.  Impotence occurs occasionally.   
Over dosage and treatment: 
        There is no specific antidote for clonidine overdosage. 
Supportive measures like atropine, ephedrine, and i.v fluids are 
enough.   
          Yohimbine partially reverses the analgesia and sedation but not 
the BP and heart rate changes produced by the epidural clonidine. 
FUTURE IMPLICATIONS;  
1. The new algorithm includes clonidine for neuropathic pain as a 
second line single drug option. 
2. Intrathecal clonidine prevents neuropathic hyperalgesia , so may be 
able to minimize the sequelae of spinal cord injury and the research 
is going on. 
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MATERIALS AND METHODS 
 
 After getting the ethical committee approval the study was 
conducted in 90 patients undergoing elective inguinal hernia surgeries. It 
was a double blinded study in which patients were randomly allocated 
into three groups A, B and C. After getting informed consent and 
explaining the procedure details to the patients, the anaesthetic technique 
was performed. 
EXCLUSION CRITERIA: 
¾ Patient refusal 
¾ ASA III & IV patients 
¾ Post spinal surgeries 
¾ Spinal deformity 
¾ H/o drug allergy 
Preoperative preparation: 
 After routine preoperative assessment as for all elective surgery 
patients , 
Patients were randomly divided into three groups. 
Group A  
     -  Received Inj. 0.5% Bupivacaine 2.4 cc+ 
                                           0.2 cc Normal saline  = 2.6 cc 
 
Group B  
      -  Received Inj. 0.5% Bupivacaine 2.4 cc + 
        Inj.Clonidine 15µg+ normal saline 0.1cc = 2.6 cc 
Group C  
      -  Received Inj. Bupivacaine 2.4 cc+ 
                 Inj. Clonidine 30 µg=2.6 cc  
  
PROCEDURE DETAILS: 
 On preoperative visit the patients were explained about the 
procedure details. Then preoperative baseline parameters like pulse rate, 
blood pressure, respiratory rate were recorded. Intravenous line started 
with 18 gauge intra venous cannula and preloaded with ringer’s lactate 15 
ml/kg 15min prior to subarachnoid blockade. 
 Following emergency drugs and equipments were kept ready before 
anaesthesia intervention. 
¾ Boyles machine with oxygen cylinder 
¾ Oxygen source 
¾ Laryngoscope with various blades 
¾ Airway in all sizes 
¾ Suction apparatus  
¾ Emergency drugs like ephedrine, dopamine, atropine and 
adrenaline 
Patients were put in right lateral position and with strict aseptic 
precaution lumbar puncture was done with quincke standard 23 guage 
spinal needle. 
After ensuing free flow of CSF, the drug was injected as per the 
group assigned. 
The assigned amount of clonidine and normal saline were taken in    
1 ml sterile tuberculine syringe.  
After injection patient were put up in supine position. After attaining 
adequate peak level of sensory block, the surgeon was asked to proceed. 
THE FOLLOWING PARAMETERS WERE RECORDED 
1. Time of highest level of sensory block achieved by pin prick. 
2. Onset and duration   of motor blockade assessed by using bromage 
scale. 
3. Pulse rate, Blood pressure, respiratory rate, spo2 were monitored 
every 5 minutes for 30 minutes and every 1 5 minutes for next 90 
min and then 30 min once for next 4 hours. 
4. Any discomfort like nausea, vomiting, dry mouth and shivering are 
noted.  
5. Hypotension is said to have occurred if the MAP falls less than  
70 mm Hg and was treated with 100% O2, Intravenous fluid bolus 
and Inj. Ephedrine in incremental doses. 
6. Bradycardia (<60/min) – if present was treated with Inj. Atropine. 
7. Sedation score was noted according to brain and ready scoring. 
8. Post operative observation: 
a. Duration of procedure 
b. Two segment regression time (i.e. the time taken to decrease 
from maximum sensory level by two segments from initial 
level is noted) 
c. Duration of postoperative analgesia. 
d. Number of  Inj.tramadol 100 mg  ampoules required in first 
24 hours. 
SEDATION SCORE: 
 Brain and Ready sedation score was employed 
 0 - Fully awake  
 1 - Drowsy 
 2 - Drowsy but arousable on touch (or) call 
 3 - Drowsy but arousable on deep stimuli 
 4 - Somnolent 
 In the post operative period total duration of analgesia was taken as 
that period from time of subarachnoid block till patient requirement of 
analgesic medicine. 
  
Pain was evaluated using VISUAL ANALOG SCALE. 
 0-1 -  Excellent    
 2-4 -  Good 
 5-6 -  Fair 
 7-8 -  Poor 
 9-10 -  No relief 
 Pain score >5   supplementary analgesia given. 
 
MOTOR BLOCK WAS ASSESSED BY BROMAGE SCALE 
0 - Full flexion of knees, feet, able to lift the extended leg 
1 - Unable to lift the extended leg. Just able to flex the knees and full  
  flexion of feet possible 
2 - Unable to flex the knees but flexion of feet possible. 
3 - Unable to move the leg (or) feet 
 Also in the post operative period all patients were followed up for 
any complications like post operative nausea, vomiting, hypotension and 
respiratory depression, dry mouth. 
 Statistical significance was brought out by ANOVA table. 
 
 
 
  
OBSERVATION AND RESULTS 
 
 In this randomized double blinded study conducted in 90 
patients, the subjects were allocated in to three groups. 
 
Group A -  Inj. 0.5% Bupivacaine 2.4cc + 0.2 cc normal saline 
 
Group B - Inj. 0.5% Bupivacaine 2.4cc+ 15 µg clonidine                         
                                                                  +0.1 cc normal saline                            
Group C   Inj.0.5% Bupivacaine 2.4cc+ Inj. Clonidine 30µg 
 
 
 
 
 
 
 
 A. PROFILE OF CASES STUDIED 
Table 1 : Age distribution 
 
Age group 
Cases in 
Group A Group B Group C 
No. % No. % No. % 
Upto 40 years 2 6.7 3 10 1 3.3 
41-50years 10 33.3 12 40 11 36.7 
51-60 years 14 46.7 12 40 12 40 
>60years 4 13.3 3 10 6 20 
Total 30 100 30 100 30 100 
Range 
Mean 
S.D. 
39-64 yrs 
52.4 
7 
39-66 yrs 
50.3 
7.5 
39-69 
52.9 
8.5 
‘p’ 0.4232 
Not significant 
 
Age distribution in the  group A ranges from  39 to 64 years with  
mean age of 52.4 years and standard  deviation of 7.In group B the age 
distribution ranges from 39-66 years with mean age of 50.3 years and 
standard deviation of 7.5. In group C the age distribution ranges from 39 to 
69 years with mean of 52.9  and standard deviation of 8.5 
The p value for three groups are not significant, so the three groups 
are comparable. 
 
 
 
  
                            Table 2: Height and weight 
 
 
Variables 
Group A Group B Group C ‘p’ 
mean S.D mean S.D mean S.D 
Height(cms) 159.5 9.0 161.1 8.3 160.8 8.3 0.7984 not 
significant
Weight(kgs) 63.6 12.6 62.5 11.0 60.1 11.1 0.3413 not 
significant
 
In group A the mean height  is 159.5 cm with standard deviation of  9 
In group B the mean height is 161.1 cm with standard deviation of  8.3 
In group C the mean height is 160.8 cm with standard deviation of 8.3 
 
In group A the mean weight is 63.6 kg with standard deviation of  12.6 
In group B the mean weight is 62.5 kg with standard deviation of 11 
In group C the mean weight is 60.1 kg with standard deviation of 11.1 
 
The p values for the height and weight of the three groups are not 
significant, so the three groups are comparable. 
 
 
 
 
 
 
  
Table 3 :   ASA status 
 
ASA 
Group A Group B Group C 
No. % No. % No. % 
I 24 80 23 76.7 21 70 
II 6 20 7 23.3 9 30 
Total 30 100 30 100 30 100 
  
 
In group A 80% belongs to ASA I and 20% ASA II 
In group B 76.7% belongs to ASA I and 23.3% ASA II 
In group C 70%  belongs to ASAI and 30% ASA II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EFFICACY OF THE THREE GROUPS 
Table 4 :  Pulse rate 
 
Pulse rate 
Group-A Group-B Group-C 
Mean S.D mean S.D Mean S.D 
Initial PR 
Minimum PR 
Average PR 
Fall  in PR 
% fall  in PR 
88.3 
75.4 
82.5 
12.8 
14.1 
9.5 
5.6 
5.9 
6.6 
6.1 
85.6 
73.1 
80.8 
12.5 
14.2 
9.8 
5.4 
6.3 
5.9 
5.4 
84.9 
67.6 
73.6 
17.4 
19.6 
11.3 
6.1 
5.3 
9.3 
8.6 
‘p’ for 3 groups 0.0159 significant 
A&B 0.9058 not significant 
B&C 0.012 significant 
A&C 0.0141 significant 
 
In group A  the initial  mean pulse rate  was 88.3 with  standard deviation 
of 9.5 per minute, reaching a minimum of 75.4 with standard deviation of 5.6 per 
minute. The mean average pulse rate was 82.5 with standard deviation of    5.9 
per minute and the percentage of fall in pulse rate was 14.1 with standard 
deviation of 6.1 
In group B the initial  mean pulse rate  was 85.6 with  standard deviation 
of 9.8 per minute, reaching a minimum of 73.1 with standard deviation of 5.4 per 
minute. The mean average pulse rate was 80.8 with standard deviation of    6.3 
per minute and the percentage of fall in pulse rate was 14.2 with standard 
deviation of 5.4 
In group C the initial mean pulse rate  was 84.9 with  standard deviation 
of 11.3 per minute, reaching a minimum of 67.6 with standard deviation of 6.1 
per minute. The mean average pulse rate was 73.6 with standard deviation of    
5.3 per minute and the  percentage of fall in pulse rate was 19.6 with standard 
deviation of  8.6 
Table 5: Mean Arterial Pressure 
 
MAP 
Group A Group B Group C 
Mean S.D Mean S.D mean S.D 
Initial MAP 
Minimum MAP 
Average MAP 
Fall in MAP 
% fall in MAP 
89.7 
83.1 
89.4 
6.6 
7.1 
6.7 
7.6 
5.6 
8.0 
7.9 
90.5 
83.2 
89.8 
7.3 
7.8 
7.5 
6.7 
4.9 
6.4 
6.8 
90.1 
78.6 
83.5 
11.5 
12.1 
8.4 
6.5 
4.3 
10.1 
10 
‘p’ for 3 groups 0.151 not significant 
A&B 0.2572 not significant 
B&C 0.0422  significant 
A&C 0.0347 significant 
 
In group A the initial mean arterial  blood pressure was 89.7 with 
standard deviation of 6.7 mm Hg, reaching a mean minimum of 83.1with 
standard deviation of 7.6 mm Hg. The average  was 89.4 with standard deviation 
of 5.6 mmHg. The  percentage  fall of 7.1 with  standard deviation of 7.9 was 
noted.  
In group B the initial mean arterial  blood pressure was 90.5with standard 
deviation of 7.5 mm Hg, reaching a mean minimum of 83.2with standard 
deviation of 6.7 mm Hg. The average  was 89.8 with standard deviation of 4.9 
mmHg. The  percentage  fall of 7.8 with  standard deviation of 6.8 was noted.  
In group C the initial mean arterial  blood pressure was 90.1 with standard 
deviation of 8.4mm Hg, reaching a mean minimum of 78.6with standard 
deviation of 6.5mm Hg. The average  was 83.5 with standard deviation of 4.3 
mmHg. The  percentage  fall of 12.1 with  standard deviation of 10  was noted.  
 
 
 
 Table 6 :  Medications 
 
Medications 
Group A Group B Group C 
No. % No. % No. % 
Inj.ephedrine 
Given 
 
3 
 
10 
 
2 
 
6.7 
 
4 
 
13.3 
Not given 27 90 28 93.3 26 86.7 
Inj. Atropine 
Given 
 
0 
 
- 
 
0 
 
- 
 
1 
 
3.3 
Not given 30 100 30 100 29 96.7 
 
In group A 3 patients received inj. Ephedrine and no patients 
received inj. Atropine. 
In group B 2 patients received inj. Ephedrine and no patients 
received inj. Atropine 
In group C 4 patients received inj. Ephedrine and one patient 
received inj. Atropine. 
 
                    
 
 
 
 
 Table 7:   Sedation score 
 
 
Sedation score 
Group A Group B Group C 
No. % No. % No. % 
0 
1 
2 
30 
- 
- 
100 
- 
- 
26 
4 
- 
86.7 
13.3 
- 
12 
18 
- 
40 
60 
- 
Mean 
S.D 
0 
- 
0.13 
0.35 
0.6 
0.4983 
‘p’ for 3 groups 0.0001 significant 
A&B 0.0280 significant 
B&C 0.0001 significant 
A&C 0.0001 significant 
 
In group A sedation was observed in no patients 
In group B grade I sedation score was observed in 4 patients  
In group C grade I sedation score was observed in 18 patients .  
 
 
 
 
 
 
  
Table 8:  Respiratory rate & SpO2 
 Respiratory rate SpO2 
Group 
A 
Group 
B 
Group 
C 
Group 
A 
Group 
B 
Group 
C 
Mean 
S.D 
14.9 
1.2 
14.8 
1.1 
14.7 
0.8 
99.7 
0.55 
99.5 
0.68 
99.6 
0.67 
“p” for 3 groups 0.5525 not significant 0.7827 not significant 
A&B 0.6894 not significant 0.4971 not significant 
B&C 0.5151 not significant 0.6309 not significant 
A&C 0.2736 not significant 0.8683 not significant 
 
In group A the mean respiratory rate  was 14.9 with standard 
deviation of 1.2 and saturation of 99.7 
In group B the mean respiratory rate  was 14.8 with standard 
deviation of 1.1and saturation of 99.5 
In group C the mean respiratory rate  was 14.7with standard 
deviation of 0.8 and saturation of 99.6 
 
 
 
 
 Table 9 :  Maximum  sensory level 
 
Max. SL 
Group A Group B Group C 
No. % No. % No. % 
T8 
T9 
T10 
T11 
3 
13 
12 
2 
10 
43.3 
40 
6.7 
3 
5 
15 
7 
10 
16.7 
50 
23.3 
7 
9 
11 
3 
23.3 
30 
36.7 
10 
Total 30 100 30 100 30 100 
 
In group A   the maximum sensory level of T8 , T9, T10, T11 was 
observed in 3, 13, 12,2 patients respectively. 
In group B   the maximum sensory level of T8 , T9, T10, T11 was 
observed in 3,5, 15,7 patients respectively. 
In group C  the maximum sensory level of T8 , T9, T10, T11 was 
observed in 7,9,11,3 patients respectively. 
 
 
 
 
 
 
 
 
 
 
 
Table 10:    Onset of max. sensory level 
Onset SL Group A Group B Group C 
Mean 
S.D 
7.9 
0.88 
8.17 
0.99 
8.83 
1.05 
‘p’  3 groups 0.0028  significant 
A&B 0.286 not significant 
B&C 0.0223 significant 
A&C 0.0008 significant 
 
In group A the onset of  maximum sensory level occurs in 7.9 
minutes with standard deviation of 0.88 
In group B the onset of  maximum sensory level occurs in 8.17 
minutes with standard deviation of 0.99 
In group C the onset of  maximum sensory level occurs in 
8.83minutes with standard deviation of 1.05 
 
 
 
 
 
 
 Table 11 :  Two segment regression 
 
2 segment 
regression 
Group A Group B Group C 
Mean 
S.D 
86.5 
7.2 
102.1 
12.5 
122.6 
5.9 
‘p’  3 groups 0.0001 significant 
A&B 0.0001 significant 
B&C 0.0001 significant 
A&C 0.0001 significant 
 
In group A the two segment regression occurred in 86.5 minutes 
with standard deviation of  7.2 
In group B the two segment regression occurred in 102.1 minutes 
with standard deviation of  12.5 
In group C the two segment regression occurred in 122.6 minutes 
with standard deviation of  5.9 
 
 
 
 
 
 Table 12  : Motor onset 
Motor onset Group A Group B Group C 
Mean 
S.D 
8.63 
1.03 
9.07 
0.83 
9.33 
0.84 
‘p’ 3 groups 0.029 significant 
A&B 0.0902 not significant 
B&C 0.2907 not significant 
A&C 0.0106 significant 
 
In group A the motor onset have occurred in 8.63 minutes with 
standard deviation of 1.03 
In group B the motor onset have occurred in 9.07 minutes with 
standard deviation of  0.83 
In group C the motor onset have occurred in 9.33 minutes with 
standard deviation of 0.84 
 
 
 
 
 
 
 
 
 
 
 
Table 13 :  Motor duration 
Motor duration Group A Group B Group C 
Mean 
S.D 
110.9 
9.9 
125.2 
9.5 
142.7 
8.5 
‘p’ 3 groups 0.0001 significant 
A&B 0.0001 significant 
B&C 0.0001 significant 
A&C 0.0001 significant 
 
In group A mean motor duration was 110.9 minutes with standard 
deviation of 9.9 
In group B mean motor duration was 125.2 minutes with standard 
deviation of 9.5 
In group C mean motor duration was 142.7 minutes with standard 
deviation of 8.5 
 
 
 
 
 
 
 
 
 Table 14 :  Duration of surgery (in minutes) 
Duration of surgery(min) Group A Group B Group C 
Mean 
S.D 
95.7 
14.8 
95.8 
9.7 
97.6 
10.7 
‘p’ 
3 groups 
 
0.7104 not significant 
A&B 0.8355 not significant 
B&C 0.4812 not significant 
A&C 0.4814 not significant 
  
 
The mean duration of surgery was 95.7, 95.8, 97.6 minutes with 
standard deviation of 14.8, 9.7, 10.7 in group A, group B, group C 
respectively 
 
 
 
 
 
 
 
 Table 15 :   Post operative analgesia ( in minutes) 
Post op analgesia(min) Group A Group B Group C 
Mean 
S.D 
175.9 
11.6 
194.9 
22.0 
272.2 
33.2 
‘p’  3 groups 0.0001  significant 
A&B 0.0001  significant 
B&C 0.0001  significant 
A&C 0.0001  significant 
 
The post operative period till the patient demands systemic analgesic 
(ie. VAS score > 5) from the initiation of subarachnoid blockade. 
In group A the mean duration of  post operative analgesia was 175.9 
minutes with standard deviation of 11.6  
In group B the mean duration of  post operative analgesia was 194.9 
minutes with standard deviation of 22 
 In group C the mean duration of  post operative analgesia was 272.2 
minutes with standard deviation of  33.2 
 
 
 
 
 
 
 
 
Table 16  :  Number  of tramadol(100mg) doses 
 
No. of tramadol doses Group A Group B Group C 
No. % No. % No. % 
1 
2 
3 
4 
- 
8 
21 
1 
- 
26.7 
70 
3.3 
- 
13 
17 
- 
- 
43.3 
56.7 
- 
12 
16 
2 
- 
40 
53.3 
6.7 
- 
Mean 
S.D 
2.77 
0.5 
2.57 
0.5 
1.67 
0.61 
‘p’  3 groups 0.0001 significant 
A&B 0.141 not significant 
B&C 0.0001 significant 
A&C 0.0001 significant 
 
In group A the mean requirement of  24 hour tramadol (100 mg) 
doses were  2, 3, 4 in 8, 21,1 patients respectively. 
In group B the mean requirement of 24 hour tramadol (100 mg) 
doses were 2,3 in 13, 17 patients respectively. 
In group C the mean requirement of 24 hour tramadol (100 mg) 
doses were 1,2,3 in  12,16,2  patients respectively 
Table 17 :   Complications 
Complications Group A Group B Group C 
No. % No. % No. % 
Shivering 4 13.3 3 10 3 10 
‘p’   A&B 0.5 not significant 
B&C 0.8 not significant 
A&C 0.5 not significant 
 
Shivering have occurred in 4 patients in group A and 3 patients in 
group B and 3 patients in group C. 
Dry mouth have not been observed in any of the cases of in  the 
three groups. 
Nausea or vomiting have not been observed in any of the patients 
the three groups. 
 
Statistical Tools : 
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2008).  
 Using this software range, frequencies, percentages, means, standard 
deviations, chi square and  'p'  values were calculated. Kruskul Wallis chi-
square test was used to test the significance of difference between 
quantitative variables and Yate’s test for qualitative variables. A 'p' value 
less than 0.05 is taken to denote significant relationship. 
DISCUSSION 
 
The pain we perceive after a burn, bite (or) pinch is readily 
identifiable but difficult to define because it is differently perceived at 
different threshold. 
 Pain is defined as psychical adjunct of protective reflex – by 
Sherington in 1906. 
 The international association of society for pain (IASP) defined it as 
“An unpleasant sensory and emotional experience associated with actual 
(or) potential tissue damage (or) described in terms of such damage” 
                 Clonidine assumes greater importance as anaesthetic adjuvant 
and analgesic. Its primary effect is sympatholytic.  It reduces 
peripheral norepinephrine release by stimulation of prejunctional 
inhibitory alpha-2 adrenoreceptors. It inhibits central neural 
transmission in the dorsal horn by presynaptic and postsynaptic 
mechanism and directly in spinal preganglionic sympathetic neurons. 
Clonidine enhances both sensory and motor blockade of local 
anaesthetics in peripheral nerve and central neuraxial blockade. 
Clonidine blocks conduction of C and A gamma fibers and increases 
potassium conductance in isolated neurons and intensifies the 
conduction of local anesthetics.  
By statistical analysis of three groups the age distribution was 
statistically not significant with a p value of 0.4232 (p> 0.05). 
When comparing the height and weight of the patients in three 
groups it was statistically not significant with a p value of 0.7984 ( p 
>0.05), 0.3413 (p>0.05) for height and weight respectively.  All the 
three  groups were comparable in relation to Age , height and Weight. 
 Duration of surgery was also comparable in all the three  groups 
with a p value of 0.7104 (p> 0.05) 
1. Post-operative analgesia was significantly prolonged in both the  
group B & C, but significantly much more in group C( 30µg 
clonidine ) .In group C , it was 272.2±33.2 minutes, while in group 
B it was 194.9±22 minutes, when compared to 175.9±11.6 minutes 
in group A. This is supported by sethi et al study where they have 
used 1µg per kg dose of clonidine with 12.5 mg of 0.5% 
bupivacaine and found that this dose prolongs the duration of post 
operative analgesia by 614 minutes in clonidine group . 
2.  24 hours inj. Tramadol (100 mg) requirement is significantly 
reduced in group C cases. The mean number of dose requirement 
was 1.67 in group C, 2.57 in group B , when compared to 2.77 in 
group A. This finding is supported by sethi et al study where they 
had used inj.diclofenac as rescue analgesic and the 24 hours 
requirement was 1.16 in clonidine group against 2.66 in control 
group.  
3.  Intra operative   sedation was  observed in group C but not of grade 
II or III or IV of brain and ready sedation score causing  either 
respiratory depression or desaturation. This observation is supported 
by sethi et al study where they have observed sedation in 50 percent 
of their patients without significant respiratory depression or 
desaturation. 
4. Hemodynamic changes: 
The fall in pulse rate was significant in three groups , but not less 
than 60 per  min in group B or group C(except in one case) requiring 
inj. Atropine to treat it. 
The fall in mean arterial pressure was not significant in three groups  
and the requirement of inj. Ephedrine is similar in all groups . But in 
sethi et al study there was significant fall in mean arterial pressure 
though not requiring vasopressor treatment. Thus doses of 30µg and 
15µg clonidine does not  produce any change in mean arterial 
pressure values and  is hemodynamically stable. 
5.  The two segment regression time was significantly prolonged in 
both the groups B and C, but more with group C. It was 122.6±5.9 
minutes in group C ,102.1±12.5 minutes in group B and 86.5±7.2 
minutes in group A. In sethi et al study also there was prolongation 
in two segment regression time of 218 minutes in clonidine 1µg per 
kg group.  
6.  The duration of motor blockade was significantly prolonged in both 
the groups B&C, but more with group C. The mean duration was 
142.7 ±8.5 minutes in group C, 125.2±9.5 minutes in group B, and 
110.9±9.9 minutes in group A . In sethi et al study the duration of 
motor blockade was 205 minutes in clonidine group.  
   7.  The onset of maximum sensory blockade and the onset of motor 
blockade was significantly prolonged in group C when compared to 
other two groups. The onset of maximum sensory level was 8.83± 
1.05, 8.17±0.99, 7.9±0.88 minutes in group C,B and A respectively. 
The duration of motor onset to achieve grade IV bromage scale was 
9.33±0.84, 9.07±0.83, 8.63±1.03 minutes in group A,B and C 
respectively. This observation is supported by sethi et al study.  
8.  The side effects of clonidine like dry mouth was not observed in any 
of the cases of group B & C . While in sethi et al study they 
observed significant incidence of dry mouth with the dose of 1µg 
per kg clonidine group. 
 
 
  
The study shows that adding clonidine 15µg and 30µg to 
bupivacaine significantly prolongs the duration of post operative 
analgesia when compared to bupivacaine alone without any side 
effects like dry mouth or hemodynamic instability. Adding 30µg of 
clonidine significantly results in more duration of post operative 
analgesia than adding 15µg of clonidine to bupivacaine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
 
     This is a randomized double blinded  study  conducted in 90 patients of 
ASA I and II undergoing elective inguinal hernia surgeries .Two different 
doses of clonidine 15 µg vs 30µg with spinal bupivacaine 2.4 ml was 
compared against 2.4 ml of  bupivacaine alone. 
    Parameters observed were time of onset of sensory block and motor 
block, two segment regression time, duration of motor blockade, 
sedation score, duration of post operative analgesia and side effects. 
1.   The post op analgesia was significantly prolonged in group C and was 
97 minutes more than the  group  A and 78 minutes more than group B. 
2.   The 24 hours analgesic requirements is significantly reduced in group 
C with 1.67 mean doses against 2.57 mean doses in group B and 2.77 
mean doses in group A 
3.   Hemodynamicaly there was no significant fall in mean arterial pressure  
in group B and group C and  the requirement of  vasopressors was similar 
in all groups. 
4.   There was significant fall in pulse rate in group c, but not to such 
extent requiring treatment, (except in one case). 
5.   Sedation was observed in group C, producing good intra operative 
comfort to the patient. Neither respiratory depression nor desaturation was 
observed in any of the case of group C. 
                          
 
CONCLUSION 
 
This study shows that adding clonidine 15µg and 30µg to 
bupivacaine significantly prolongs the duration of post operative 
analgesia when compared to bupivacaine alone in inguinal hernia 
surgeries. Adding 30µg of clonidine significantly results in more 
duration of post operative analgesia than adding 15µg of clonidine to 
bupivacaine without any side effects. 
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                                  PROFORMA 
 
A COMPARATIVE STUDY OF TWO DOSES OF 
INTRATHECAL CLONIDINE WITH BUPIVACAINE 
IN INGUINAL HERNIA SURGERIES  
 
 
  
AIM:   
To assess the degree of post-op analgesia provided by 2 varying doses of 
clonidine with bupivacaine against  bupivacaine alone in inguinal  hernia surgeries. 
 
NAME : 
AGE/SEX : 
IP.NO  : 
WARD/SU : 
DATE  : 
ASA  : 
ANY MEDICAL ILLNESS : 
PT. ON ANY DRUGS : 
(tick any one) 
GROUP-A :  0.5% BUP.   2.4 ml + 0.2 ml NS                                            
GROUP-B  :  0.5% BUP.   2.4 ml + 15 mics CLONIDINE + 0.1 ml NS 
GROUP –C :  0.5%BUP.   2.4 ml +  30 mics CLONIDINE 
TIME OF SAB: 
PATIENT POSITION : 
SPINAL NEEDLE- GAUGE :23 G 
Time of SAB Time to reach 
highest level of 
sensory blockade 
Time to obtain grade 
IV motor 
block(bromagescale)
Time to reach           
2- segment 
regression 
 
 
   
Note : Time to be evaluated every 1 minute till it reach the target level 
POST-OP ANALGESIA   :  by VAS scoring 
Time to get first ANALGESIC DOSE 
DURATON OF SURGERY : 
 
 
Time SPO2 RR NIBP PR Any 
medications
Sedation 
score 
Side 
effects 
Pre-op        
SAB         
5 MIN        
1O m        
15 m        
20 m        
25 m        
30 m        
45 m        
1 hr        
1hr 15m        
1hr 30m        
2 hrs        
2.30 hrs        
3 hrs        
3.30 hrs        
4 hrs        
4.30 hrs        
5 hrs        
5.30 hrs 
6 hrs 
       
 
 
 
 
MEDICATIONS :  Inj. ATROPINE O.6mg i.v  if PR< 60/min 
                                If MAP < 70 mmHg ; rush IV FLUID 
                                                                   Inj. Ephedrine 3 mg (repeated if needed) 
                                                                   O2 supplementation, foot end elevation  
SIDE- EFFECTS ; 1.  shivering 
                              2.  nausea, retching, vomiting 
                              3.  sedation 
                              4.  dry mouth 
OBSERVATIONS; 
SENSORY BLOCKADE :  
By pin prick every 5 min till it reaches the highest level  
MOTOR BLOCKADE; (bromage scale) every 5 min till grade 4 is 
reached. 
 
1- free movt. of  legs / feet 
 
2- just able to flex knees with free movt. of feet 
 
3- unable to flex knees, but with free movt. of feet 
 
4- unable to move legs/ feet 
 
BELVILLE’S SCORE; 
 
1- nausea; subjective unpleasant sensation with an urge to vomit 
 
2- retching; laboured, spasmodic, rhythmic contraction of respiratory 
muscle 
 
3- vomiting; retching with expulsion of  gastric contents. 
 
SHIVERING:  (crossley & mahajan scoring) 
 
1- pilo erection 
 
2- contraction of any one muscle group 
 
3- contraction of more than one muscle group 
 
4- whole body shivering 
 
 
SEDATION SCORE; (brain and ready scoring) 
 
0- Fully awake 
 
1- drowsy 
 
2- drowsy but arousable to touch / call 
 
3- drowsy but arousable on deep stimuli 
 
4- somnolent 
 
Pain was evaluated using VISUAL ANALOG SCALE. 
 0-1 - Excellent    
 2-4 - Good 
 5-6 - Fair 
 7-8 - Poor 
 9-10 - No relief 
Pain score >5 – supplementary analgesia given 
 
 In the post operative period total duration of analgesia was taken as that 
period from time of subarachnoid block till patient requirement of analgesic (inj. 
Tramadol 100 mg). 
 
 
 
 
 
 
 
 
 
 
 
No. % No. % No. %
Upto 40 years 2 6.7 3 10 1 3.3
41-50years 10 33.3 12 40 11 36.7
51-60 years 14 46.7 12 40 12 40
>60years 4 13.3 3 10 6 20
Group A 30
Group B 30
Group C 30
No. % No. % No. %
I 24 80 23 76.7 21 70
II 6 20 7 23.3 9 30
No. % No. % No. %
Inj.ephedrine
Given 3 10 2 6.7 4 13.3
Not given 27 90 28 93.3 26 86.7
Inj. Atropine
Given 0 0 0 0 1 3.3
Not given 30 100 30 100 29 96.7
No. % No. % No. %
Inj. Epidrine 
Given
3 10 2 6.7 4 13.3
Not given 27 90 28 93.3 26 86.7
Inj. Atropine 
Given
0 0 0 0 1 3.3
Not given 30 100 30 100 29 96.7
Group A Group B Group C
Age in Years
ASA
Group A Group B Group C
Group A Group B Group Cmedications
medications Group A Group B Group C
No. % No. % No. %
0 30 100 26 86.7 12 40
1 0 0 4 13.3 12 40
2 0 0 0 0 6 20
Group A 14.1
Group B 14.2
Group C 19.6
Group A 7.1
Group B 7.8
Group C 12.1
Group A 0.1
Group B 0.13
Group C 0.8
No. % No. % No. %
T8 3 10 3 10 7 23.3
T9 13 43.3 5 16.7 9 30
T10 12 40 15 50 11 36.7
T11 2 6.7 7 23.3 3 10
Group A 7.9
Group B 8.17
Group C 8.83
Group A 86.5
Group B 102.1
Group C 122.6
Group A Group B Group CSedation score
Gr‐A Gr‐B Gr‐CMax. SL
Group A 175.9
Group B 194.9
Group C 272.2
Group A 110.9
Group B 125.2
Group C 142.7
Group A 8.63
Group B 9.07
Group C 9.33
Group A 2.77
Group B 2.57
Group C 1.67
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1 42967 A 45 M 148 36 I 96 78 82 87 83 89 0 0 0 16 99 T10 8m 94m 10m 112 96 no no 184m 3
2 39836 A 55 M 156 46 I 106 89 94 89 85 91 0 0 0 14 100 T9 7m 88m 8m 122 104 no no 166m 2
3 44478 A 49 M 163 74 I 89 79 82 96 92 98 0 0 0 16 99 T9 8m 92m 9m 126 90 no no 190m 3
4 44219 A 40 M 148 82 I 78 74 82 97 91 89 0 0 0 15 100 T10 10m 84m 10m 118 78 no no 170m 3
5 44039 A 56 M 162 86 I 86 76 79 79 79 83 0 0 0 15 100 T8 7m 98m 8m 126 106 no no 202m 3
6 44676 A 60 M 168 58 I 92 70 84 87 83 89 0 0 0 16 100 T9 9m 88m 10m 118 98 no yes 160m 3
7 44181 A 62 M 162 62 I 97 83 89 93 89 96 0 0 0 13 100 T10 7m 80m 8m 102 90 no no 170m 3
8 46874 A 48 M 158 68 I 76 70 71 83 79 82 0 0 0 12 99 T9 8m 94m 8m 110 78 no no 190m 2
9 46864 A 52 M 155 48 I 68 65 76 87 83 89 0 0 0 14 100 T9 8m 78m 9m 96 96 no no 174m 3
10 46570 A 54 M 171 64 I 89 84 83 93 93 97 0 0 0 15 99 T8 7m 88m 8m 94 102 no no 168m 2
11 44412 A 64 M 172 72 II 91 72 81 103 69 93 1 0 0 16 99 T8 9m 92m 9m 112 98 no no 156m 3
12 48861 A 58 M 168 78 I 79 69 84 93 86 89 0 0 0 13 100 T9 8m 98m 9m 122 120 no yes 194m 2
13 45866 A 60 M 156 58 I 88 72 77 79 67 77 1 0 0 14 100 T10 7m 74m 8m 98 102 no no 188m 3
14 48846 A 53 I 149 53 II 93 75 83 88 83 91 0 0 0 14 100 T10 9m 86m 9m 102 114 no no 176m 3
15 46969 A 49 M 145 47 I 76 69 71 97 93 98 0 0 0 15 100 T9 8m 88m 8m 104 126 no no 170m 3
16 47879 A 42 M 166 38 I 84 74 77 101 66 93 1 0 0 15 100 T10 7m 78m 7m 106 120 no no 190m 2
17 48505 A 47 M 173 66 I 78 71 73 83 79 85 0 0 0 14 100 T11 9m 76m 10m 112 80 no yes 166m 3
18 48510 A 56 M 148 63 I 96 75 83 93 93 97 0 0 0 15 99 T11 7m 78m 10m 124 70 no no 158m 3
19 48534 A 59 M 172 59 I 81 71 92 97 91 96 0 0 0 16 100 T9 8m 90m 8m 126 88 no no 182m 3
20 47070 A 48 M 149 56 II 87 80 81 92 83 89 0 0 0 17 100 T10 7m 80m 7m 114 90 no no 176m 3
21 47721 A 52 M 167 64 I 94 79 83 77 75 81 0 0 0 15 100 T10 9m 78m 10m 96 102 no yes 180m 3
22 46193 A 42 M 153 62 I 104 76 89 83 79 84 0 0 0 16 100 T10 9m 96m 10m 120 92 no no 170m 2
23 48965 A 39 M 158 86 I 97 83 91 89 81 87 0 0 0 15 100 T10 7m 92m 8m 114 88 no no 182m 2
24 48327 A 48 M 148 78 I 106 80 89 93 93 97 0 0 0 14 98 T10 8m 80m 9m 102 82 no no 166m 3
25 47764 A 51 M 163 64 II 89 81 92 91 85 89 0 0 0 15 100 T9 7m 84m 7m 106 78 no no 170m 3
26 106976 A 62 M 169 73 I 72 66 81 89 81 87 0 0 0 16 99 T9 8m 90m 8m 114 70 no no 160m 4
27 103113 A 46 M 172 64 II 88 73 82 79 75 81 0 0 0 13 99 T9 9m 84m 10m 102 96 no no 176m 3
28 106959 A 62 M 155 66 I 87 80 82 87 81 86 0 0 0 15 100 T9 7m 78m 7m 98 120 no no 170m 3
29 1839 A 54 M 149 68 II 89 76 79 89 84 87 0 0 0 16 100 T10 8m 92m 9m 114 106 no no 190m 2
30 1688 A 58 M 162 70 I 92 73 83 97 91 93 0 0 0 16 100 T9 7m 96m 8m 116 90 no no 182m 3
31 1680 B 44 M 142 39 I 107 82 91 89 79 87 0 0 0 14 100 T10 7m 106m 8m 132 96 no no 206m 2
32 3718 B 48 M 148 44 II 97 79 89 91 83 89 0 0 0 15 98 T9 8m 96m 9m 118 110 no no 186m 3
33 3999 B 52 M 156 48 I 73 65 79 93 87 91 0 0 0 16 99 T8 9m 102m 10m 132 90 no no 110m 2
34 4826 B 56 M 167 49 I 87 72 79 97 91 96 0 0 0 14 99 T11 8m 90m 8m 116 88 no no 170m 3
35 48918 B 58 M 168 50 II 97 74 85 79 79 83 0 0 0 15 99 T10 7m 86m 8m 128 76 no no 202m 3
36 96416 B 59 M 166 54 I 77 67 71 83 81 85 0 0 0 16 99 T11 9m 110m 7m 128 90 no no 180m 2
37 99372 B 66 M 169 57 I 73 65 82 87 83 89 0 0 0 14 99 T10 7m 122m 8m 136 98 no no 210m 2
38 99189 B 62 M 174 52 I 86 75 81 101 93 97 0 0 1 15 100 T10 8m 88m 9m 102 102 no yes 214m 3
39 99861 B 55 M 173 66 II 92 80 87 103 87 93 0 0 0 13 100 T9 9m 96m 10m 118 116 no no 196m 2
40 98104 B 45 M 166 67 I 88 79 83 97 89 95 0 0 0 12 100 T8 7m 106m 9m 132 98 no no 188m 2
41 98976 B 40 M 168 64 I 78 72 73 79 77 81 0 0 0 15 100 T10 8m 108m 10m 128 88 no no 192m 3
42 98972 B 39 M 146 63 II 93 73 84 83 83 86 0 0 0 16 100 T11 9m 109m 10m 126 92 no no 178m 3
43 99810 B 43 M 154 69 I 97 72 85 87 81 86 0 0 0 17 100 T10 7m 114m 9m 134 92 no no 192m 3
44 101981 B 56 M 156 77 I 104 84 91 93 79 89 0 0 0 15 100 T9 8m 112m 9m 131 88 no no 194m 2
45 161596 B 43 M 152 78 I 79 70 88 97 89 93 0 0 1 16 100 T10 9m 92m 10m 108 86 no yes 196m 2
46 101700 B 47 M 163 73 II 83 73 77 92 67 91 1 0 0 14 99 T8 9m 96m 9m 118 82 no no 211m 3
47 98867 B 39 M 166 72 I 97 82 85 101 93 97 0 0 0 14 99 T11 10m 98m 10m 122 98 no no 212m 2
48 99760 B 41 M 163 67 I 77 70 74 103 87 95 0 0 0 15 98 T10 7m 94m 9m 128 102 no no 214m 3
49 101745 B 42 M 169 64 I 69 64 77 77 77 81 0 0 0 14 100 T11 9m 102m 10m 124 114 no no 240m 3
50 100640 B 47 M 147 56 I 78 67 68 83 79 84 0 0 1 14 100 T10 9m 106m 10m 122 92 no no 210m 2
51 104134 B 48 M 156 53 I 74 66 71 86 81 87 0 0 0 14 100 T10 8m 104m 8m 128 104 no no 180m 3
52 103113 B 51 M 158 59 II 79 68 73 89 83 91 0 0 0 15 100 T9 7m 116m 9m 142 106 no no 176m 3
53 28285 B 52 M 160 60 I 86 72 79 91 66 93 1 0 0 15 100 T10 9m 118m 9m 138 92 no no 180m 2
54 30162 B 56 M 166 73 II 89 74 81 93 91 93 0 0 0 16 100 T11 10m 114m 10m 132 78 no no 190m 2
55 30756 B 48 M 162 79 I 93 76 87 97 91 96 0 0 0 14 100 T10 8m 104m 9m 128 96 no no 196m 3
56 30734 B 47 M 167 85 I 88 72 79 93 87 91 0 0 0 15 100 T9 9m 108m 9m 124 102 no yes 202m 2
57 6568 B 56 M 168 66 I 91 80 87 99 91 97 0 0 1 16 99 T10 9m 68m 10m 102 104 no no 214m 3
58 6613 B 52 M 157 68 I 77 75 75 83 83 87 0 0 0 14 98 T11 7m 74m 9m 122 92 no no 202m 3
59 6215 B 64 M 159 57 I 78 71 86 81 79 83 0 0 0 15 100 T10 7m 110m 8m 126 96 no no 214m 3
60 4378 B 52 M 166 66 I 81 74 77 89 81 87 0 0 0 16 100 T10 7m 114m 9m 132 106 no no 192m 3
61 6668 C 45 M 142 38 I 106 71 77 86 77 83 0 0 1 14 100 T9 9m 126m 10m 148 96 no no 222m 2
62 5014 C 46 M 147 45 I 109 73 76 79 76 81 0 0 1 15 99 T8 10m 120m 10m 152 110 no no 246m 3
63 6601 C 48 M 155 49 I 79 62 67 94 86 89 0 0 0 16 98 T10 11m 130m 11m 160 80 no no 262m 2
64 7842 C 55 M 166 50 I 89 67 73 97 79 81 0 0 1 14 99 T8 9m 132m 9m 158 78 no no 242m 1
65 20270 C 56 M 172 55 I 92 75 78 99 83 85 0 0 0 14 100 T9 10m 110m 10m 130 94 no no 276m 1
66 9899 C 54 M 173 56 I 70 63 66 101 74 79 0 0 0 15 100 T8 11m 120m 11m 136 96 no no 278m 2
67 20366 C 66 M 148 58 II 76 64 69 104 77 83 0 0 1 16 100 T10 8m 126m 9m 146 84 no no 322m 1
68 6590 C 73 M 155 65 I 83 69 74 91 67 79 1 0 1 14 100 T9 9m 118m 10m 130 92 no no 284m 1
69 8476 C 67 M 167 68 II 96 73 79 77 74 79 0 0 1 15 100 T8 7m 130m 8m 142 114 no no 286m 1
70 8490 C 54 M 163 70 I 79 71 73 81 79 83 0 0 1 14 99 T9 8m 118m 9m 144 110 no no 284m 1
71 21665 C 53 M 168 84 I 83 73 76 85 83 86 0 0 0 15 100 T8 9m 128m 10m 146 98 no no 266m 2
72 24717 C 44 M 169 56 I 69 61 73 93 89 91 0 0 0 14 100 T9 10m 124m 10m 142 106 no no 256m 2
73 24388 C 39 M 170 57 II 78 69 73 97 79 81 0 0 1 14 99 T10 9m 126m 10m 142 110 no no 196m 2
74 21152 C 45 M 172 53 I 82 71 74 77 74 79 0 0 0 15 98 T11 8m 130m 9m 152 88 no no 296m 2
75 27282 C 42 M 155 66 I 87 69 73 103 91 93 0 0 1 13 99 T10 9m 134m 10m 148 78 no no 292m 1
76 26433 C 46 M 158 69 II 91 52 79 101 68 77 1 1 1 15 100 T9 8m 132m 9m 150 102 no no 291m 1
77 27986 C 47 M 167 82 I 97 71 79 88 77 81 0 0 1 14 100 T10 7m 120m 8m 142 114 no no 284m 2
78 27982 C 55 M 166 64 II 102 77 82 83 81 85 0 0 1 15 100 T11 9m 118m 9m 130 90 no no 296m 2
79 26392 C 42 M 156 84 I 88 68 73 89 83 87 0 0 0 15 100 T8 10m 122m 10m 142 96 no yes 288m 2
80 28882 C 46 M 169 44 II 91 66 70 93 86 89 0 0 1 16 100 T9 9m 124m 9m 146 86 no no 294m 1
81 28013 C 52 M 163 48 II 97 67 71 77 73 79 0 0 0 15 100 T10 8m 116m 8m 138 98 no no 326m 1
82 41456 C 53 M 167 66 I 79 69 73 96 83 86 0 0 0 14 100 T11 10m 118m 10m 142 110 no no 312m 1
83 40148 C 60 M 155 64 I 69 61 63 91 79 81 0 0 0 15 99 T9 9m 114m 9m 128 106 no no 318m 1
84 30500 C 67 M 158 56 I 72 64 69 83 81 85 0 0 1 15 98 T8 8m 120m 9m 136 104 no yes 241m 2
85 32348 C 61 M 154 58 I 66 60 62 91 65 77 1 0 1 16 100 T10 8m 124m 9m 142 114 no no 186m 3
86 38853 C 62 M 149 67 II 93 74 79 101 67 81 1 0 1 14 100 T10 9m 122m 9m 148 102 no no 262m 2
87 39659 C 55 M 166 62 I 77 54 82 97 86 89 0 0 0 15 100 T10 7m 116m 8m 126 96 no no 276m 2
88 36722 C 57 M 155 54 I 76 66 69 79 78 81 0 0 0 14 100 T10 8m 118m 8m 138 92 no yes 268m 2
89 40789 C 52 M 158 58 II 79 69 73 83 79 85 0 0 1 14 100 T9 9m 122m 10m 146 94 no no 271m 2
90 43009 C 46 M 160 56 I 93 78 83 87 85 89 0 0 1 15 100 T10 9m 120m 9m 152 90 no no 244m 2
